Uematsu et al. have shown that the dedifferentiation of breast cancer cells that lose estrogen receptor expression and transition from a luminal to a basal breast cancer after passage can be counteracted by inhibiting NOTCH signaling [181]. Here, ESR1 is linked to breast carcinoma.